Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Day One Biopharmaceuticals (DAWN) Tax Provisions (2024 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Tax Provisions for 2 consecutive years, with $2.0 million as the latest value for Q4 2025.

  • Quarterly Tax Provisions fell 69.12% to $2.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Dec 2025, down 72.05% year-over-year, with the annual reading at $2.0 million for FY2025, 72.17% down from the prior year.
  • Tax Provisions for Q4 2025 was $2.0 million at Day One Biopharmaceuticals, down from $6.4 million in the prior quarter.
  • The five-year high for Tax Provisions was $6.4 million in Q4 2024, with the low at -$882000.0 in Q3 2024.